timothy sykes logo

Stock News

GlucoTrack Stock Surges Amid Major Investment and Capital Infusion

Ellis HobbsAvatar
Written by Ellis Hobbs Reviewed by Jack Kellogg Fact-checked by Tim Sykes
Updated 9/13/2025, 9:16 am ET 9/13/2025, 9:16 am ET | 5 min 5 min read
GlucoTrack Stock Surges Amid Major Investment and Capital Infusion Thumbnail

GlucoTrack Inc. stocks have been trading up by 80.7 percent after securing expanded FDA designations.

Healthcare industry expert:

Analyst sentiment – neutral

GlucoTrack Inc. (GCTK) currently displays significant financial challenges, with critical performance metrics indicating severe profitability issues. The company’s EBIT and EBITDA figures are deeply negative, standing at -$4,756,000 and -$4,743,000, respectively, illustrating a substantial operational loss. The balance sheet reveals a concerning retained earnings deficit of $143,998,000, further highlighting the company’s financial distress. Despite a decent liquidity position suggested by a quick ratio of 3.1 and a current ratio of 3.3, the company’s valuation measures such as a price-to-book ratio of 0.64 and negative cash-flow indicators indicate a deep undervaluation potentially fueled by the company’s current unprofitability and substantial negative return on equity of -1,490.95%.

Analyzing recent price data, GCTK has experienced substantial volatility, with prices closing at $8.8 on September 12, following a high of $12.28. This significant price surge was likely catalyzed by the recent announcement of a sizable investment from Sixth Borough Capital Fund. The weekly price pattern suggests an upward breakout sustained by increased trading volume. A potential bullish continuation pattern may form, creating an opportunity for a short-term long position. Traders should monitor the $8.80 support level, holding for a potential move towards resistance at $12.00. Clearly identified volume increases and daily volatility affirm these key technical levels.

Recent strategic developments, primarily driven by the agreement with Sixth Borough Capital Fund to purchase up to $20 million in shares, could provide much-needed financial relief and operational longevity. This event catalyzed a meteoric rise in the stock price, reflecting investor optimism about future operational capabilities and funding for continued innovation in diabetes management technology. However, comparative to global healthcare and medical equipment benchmarks, GCTK remains an underperforming entity with high-risk implications. Current trading above the pivotal $8.00 level indicates speculative interest; however, reaching and sustaining a price above the noted resistance level is crucial for any long-term positive sentiment. Overall, while short-term prospects have improved on deal news, a sustained performance turnaround is critical for long-term viability.

Candlestick Chart

Weekly Update Sep 08 – Sep 12, 2025: On Saturday, September 13, 2025 GlucoTrack Inc. stock [NASDAQ: GCTK] is trending up by 80.7%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

GlucoTrack, experiencing rapid market movements, has undergone noteworthy financial fluctuations recently. The stock opened strong, closing up significantly with intraday charts reflecting substantial volatility. On September 12, it opened at $10.59 before seeing a high of $12.28 and closing at $8.8, signaling intense trading activity. This volatility stems mainly from strategic corporate maneuvers including significant share transactions with Sixth Borough Capital, outlined in recent announcements.

Financial metrics display an intricate picture. The company holds a current ratio of 3.3 and a quick ratio of 3.1, suggesting solid short-term financial health. However, a negative cash flow from operations and substantial accumulated revenue declines demonstrate financial challenges. Despite an enterprise value standing at $11.35M and a relatively low price-to-book ratio of 0.64, negative profitability ratios point toward operational hurdles GCTK must tackle.

Notably, recent increases in stock price driven by external financial backing are key. Sixth Borough Capital’s involvement provided significant liquidity infusion, which may offer breathing room financially while bolstering investor confidence. However, sustainable profit-growth strategies are crucial as monetary pressures from past operational losses remain.

More Breaking News

Conclusion: Evaluating Market Trajectory

Reflecting on GlucoTrack’s current trajectory highlights a landscape ripe with opportunity but laden with challenges. A series of strategic financial moves, particularly the capital commitment from Sixth Borough, are pivotal in elevating GlucoTrack’s market standing, leading to eye-catching price rallies. Such strategic partnerships also underline trader confidence in GCTK’s potential, an essential asset for further growth avenues. As millionaire penny stock trader and teacher Tim Sykes, says, “There is always another play around the corner; don’t chase just because you feel FOMO.” It’s essential that traders remain cautious and avoid getting swept away by momentary price spikes.

Nonetheless, it is crucial to weigh these developments against existing financial hurdles. As past receipts continue showing operational profitability concerns, future growth relies heavily on leveraging injected capital towards effective business streamlining. Measures aimed at optimizing cash flows while elevating revenue streams present clear paths forward amid the current market dynamics. Traders may find robust returns if GCTK successfully navigates these challenges, capitalizing on newfound financial backing while turning operational capacities towards sustained profitability.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Ellis Hobbs

Trainer and Mentor on Tim Sykes’ Trading Challenge
He teaches webinars on Tim Sykes’ Trading Challenge He treats trading like a business, not a hobby He emphasizes taking small risks — “If you get the process right, money is a forgone conclusion.”
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”